Actively Recruiting
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
Led by Abbott Diabetes Care · Updated on 2025-01-15
800
Participants Needed
2
Research Sites
114 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is to see if the FreeStyle Libre 3 Continuous Glucose Monitoring System (FSL3) will help prolong the length of time people with diabetes maintain adherence to glucagon-like peptide 1 (GLP-1/GIP) agonists.
CONDITIONS
Official Title
Prolongation of GLP-1 Adherence When Using Continuous Glucose Monitoring
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subject must be at least 18 years of age.
- Subject must be able to read and understand English.
- Subject must have a type 2 diabetes diagnosis.
- Subject must meet criteria to begin GLP-1 or GIP/GLP-1 medication for diabetes management.
- Subject is starting GLP-1 or GIP/GLP-1 medication for diabetes.
- Subject must be willing to provide venous blood samples to test HbA1c.
- Subject must be willing to use either their current standard care device or the FreeStyle Libre 3 CGM during the study.
- Subject must be able to follow study instructions and complete all required tasks.
- Subject must be available for all study visits.
- Subject must be willing and able to give written informed consent.
You will not qualify if you...
- Subject is a member of the Study Staff.
- Subject has type 1 or gestational diabetes.
- Subject has used GLP-1 or GIP/GLP-1 drugs previously or currently.
- Subject currently uses a continuous glucose monitor as their standard care.
- Subject has known allergy to medical grade adhesive, isopropyl alcohol, or ethyl alcohol used in skin disinfection.
- Subject is taking rapid-acting insulin, including NPH and premix insulin.
- Subject has a medical condition that may interfere with the study or pose safety risks.
- Subject is currently enrolled in another clinical trial.
- Subject is unsuitable for participation for any other reason determined by the Investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
East Coast Institute for Research, LLC
Jacksonville, Florida, United States, 32216
Actively Recruiting
2
Excellence Medical and Research
Miami Gardens, Florida, United States, 33169
Actively Recruiting
Research Team
M
Mohamed Mohamed Nada, PhD
CONTACT
S
Shridhara Karinka, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here